Stock Upgrades Today

 TopRated
 
  TopRated
 
Follow  Message
 
 
 
TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.
 

•  28 Jan 2026
 

•   ALIT  
   
  -1.29%
•   AMAT  
   
  +1.61%
•   APH  
   
  +0.90%
•   ASB  
   
  +0.70%
•   AXL  
   
  -0.49%

$ALIT continues to draw attention after KeyBanc highlighted an inflection point following a volatile year in healthcare IT. Despite a sharp price target cut, the firm maintained an Overweight rating, signaling longer-term confidence even as near-term uncertainty lingers.

$AMAT earned an upgrade from Mizuho to Outperform as wafer fabrication equipment spending accelerates. With semiconductor capital expenditures gaining traction, Applied Materials is increasingly viewed as a leveraged play on AI-driven chip demand.

$APH crossed above its average analyst target price and faced downgrade pressure as valuation questions emerge. After a massive run, expectations were elevated, and traders now have to assess whether growth can justify the premium.

$ASB was upgraded to Buy by Zacks, reflecting improving earnings prospects. Regional banks have been highly sensitive to rate expectations, and upgrades like this can attract short-term rotation into financials.

$AXL initiated with a Buy by BWS Financial brings renewed focus to auto suppliers. Even with forecast volatility, initiation coverage often draws fresh institutional attention.

$BA saw UBS reiterate its Buy rating with a $275 target, citing improving aerospace trends and Dreamliner production. Defense and geopolitical spending continue to underpin sentiment in the sector.

$BBNX was initiated with a Hold rating by TD Cowen despite a significant implied upside forecast. For traders, the Hold suggests analysts want more execution clarity before turning fully bullish.

$BRO was downgraded to Neutral at Citi as the rebound pace moderates. Insurance brokers have been steady performers, but slowing momentum can cap near-term upside.

$CGAU crossed above its average analyst target, prompting valuation concerns. Gold names often react sharply when expectations get ahead of price targets.

$CNC faced a downgrade based on timing rather than core fundamentals. Managed care remains policy-sensitive, and traders must watch regulatory risk closely.

$CNI was upgraded to Outperform from Neutral by CIBC, with double-digit upside implied. Railroads tend to attract investors during economic stabilization phases.

$COIN was initiated at Neutral by Baird with a $240 target. Coinbase remains tied closely to crypto volatility, making sentiment and Bitcoin price action key drivers.

$DDOG was initiated with a Buy rating by Daiwa Capital, signaling optimism around cloud monitoring demand. Software names with AI exposure remain closely watched.

$DOCU continues to receive constructive coverage, with multiple Buy ratings and no Sell calls. As enterprise digitization persists, traders are looking for signs of reacceleration.

$DT was upgraded to Buy by Zacks, reflecting stronger earnings expectations. Dynatrace remains positioned within observability and AI analytics growth trends.

$EXPE carries a more cautious tone despite B2B momentum, with a Sell call highlighting uneven sentiment in travel-related equities.

$FE was upgraded to Outperform by Wolfe Research, with modest upside implied. Utilities upgrades often attract defensive capital flows.

$GM is being framed as a strong Buy despite trading near highs. The market is weighing EV strategy execution and margin resilience.

$HCA crossed above its analyst target price, often a precursor to rating adjustments. Healthcare providers remain sensitive to reimbursement trends.

$ISRG was upgraded from Hold to Buy, reflecting confidence in surgical robotics growth. The implied upside could draw renewed growth investors.

$JNJ was upgraded at Morgan Stanley on improved growth visibility, reinforcing confidence in diversified healthcare exposure.

$LHX maintains a Neutral stance despite benefiting from rising defense budgets. Investors may await clearer catalysts before committing fresh capital.

$LITE retains a Buy rating at Citi, with optical and telecom demand supporting the narrative.

$MDB continues to hold a Buy view at William Blair, supported by database and cloud growth.

$MGY was upgraded by Wells Fargo from Underweight to Equal-Weight, signaling improving energy sentiment.

$NFLX was upgraded from Hold to Buy, with meaningful upside potential cited. Streaming competition remains intense, but subscriber momentum matters.

$NTR was upgraded to Strong Buy by Zacks, reflecting optimism around earnings prospects in agriculture inputs.

$OKLO was initiated with a Buy rating, positioning it as an emerging nuclear energy growth story with notable upside projections.

$PR earned an IBD rating upgrade as price strength improved, often a technical signal traders watch closely.

$RMTI was upgraded to Buy, reflecting improving earnings outlook in specialty healthcare.

$SITC maintains an Overweight rating despite estimate revisions, highlighting income appeal for yield-focused investors.

$TEL was upgraded to Outperform, with solid upside implied as connectivity demand expands.

$TRP crossed above its analyst target, potentially prompting valuation reassessment in the pipeline space.

$TXN received a notable upgrade from Morgan Stanley, shifting to Overweight and raising the price target significantly. As a semiconductor bellwether, sentiment here can ripple across the sector.

$ZIM was upgraded to Buy by Zacks, reflecting improving earnings expectations in shipping, a sector known for sharp cyclical swings.

View All Headlines